Publications by Even Walseng
16 publications found
Original articles
Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers
Front Immunol, 14, 1275304
DOI 10.3389/fimmu.2023.1275304, PubMed 38022650
Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-Cλ interface
MAbs, 15 (1), 2273449
DOI 10.1080/19420862.2023.2273449, PubMed 37930310
Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform
Immunooncol Technol, 10
DOI 10.1016/j.iotech.2021.100034, PubMed 35174321
Monitoring Protein Endocytosis and Recycling Using FACS-Based Assays
Methods Mol Biol, 1988, 279-288
DOI 10.1007/978-1-4939-9450-2_20, PubMed 31147947
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates
Nat Commun, 8 (1), 1112
DOI 10.1038/s41467-017-01257-1, PubMed 29062027
A TCR-based Chimeric Antigen Receptor
Sci Rep, 7 (1), 10713
DOI 10.1038/s41598-017-11126-y, PubMed 28878363
Chemically Programmed Bispecific Antibodies in Diabody Format
J Biol Chem, 291 (37), 19661-73
DOI 10.1074/jbc.M116.745588, PubMed 27445334
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
Oncoimmunology, 5 (5), e1138199
DOI 10.1080/2162402X.2016.1138199, PubMed 27467957
Unpredicted phenotypes of two mutants of the TcR DMF5
J Immunol Methods, 425, 37-44
DOI 10.1016/j.jim.2015.06.006, PubMed 26079729
Soluble T-cell receptors produced in human cells for targeted delivery
PLoS One, 10 (4), e0119559
DOI 10.1371/journal.pone.0119559, PubMed 25875651
Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
Gene Ther, 22 (5), 391-403
DOI 10.1038/gt.2015.4, PubMed 25652098
The fusion of early endosomes induces molecular-motor-driven tubule formation and fission
J Cell Sci, 125 (Pt 8), 1910-9
DOI 10.1242/jcs.092569, PubMed 22357949
Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity
PLoS One, 7 (9), e45422
DOI 10.1371/journal.pone.0045422, PubMed 23028998
Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells
Proc Natl Acad Sci U S A, 107 (47), 20465-70
DOI 10.1073/pnas.1010990107, PubMed 21059907
Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus
J Biol Chem, 285 (53), 41749-54
DOI 10.1074/jbc.M110.157586, PubMed 21047782
Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway
J Biol Chem, 283 (21), 14717-27
DOI 10.1074/jbc.M801070200, PubMed 18378669